Previous Article | Next Article 
Journal of Virology, September 2000, p. 8480-8486, Vol. 74, No. 18
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Efficient Cell Infection by Moloney Murine Leukemia
Virus-Derived Particles Requires Minimal Amounts of Envelope
Glycoprotein
Estanislao
Bachrach,
Mariana
Marin,
Mireia
Pelegrin,
Georgios
Karavanas, and
Marc
Piechaczyk*
Institut de Génétique
Moléculaire, UMR 5535/IFR24, CNRS, BP 5051, 34293 Montpellier
Cedex 05, France
Received 23 March 2000/Accepted 20 June 2000
 |
ABSTRACT |
Retrovirus entry into cells is mediated by specific interactions
between the retrovirally encoded Env envelope glycoprotein and a host
cell surface receptor. Though a number of peptide motifs responsible
for the structure as well as for the binding and fusion activities of
Env have been identified, only a few quantitative data concerning the
infection process are available. Using an inducible expression system,
we have expressed various amounts of ecotropic and amphotropic Env at
the surfaces of Moloney murine leukemia virus-derived vectors and
assayed for the infectivity of viral particles. Contrary to the current
view that numerous noncooperative Env-viral receptor interactions are
required for cell infection, we report here that very small amounts of
Env are sufficient for optimal infection. However, increasing Env density clearly accelerates the rate at which infectious attachment to
cells occurs. Moreover, our data also show that a surprisingly small
number of Env molecules are sufficient to drive infection, albeit at a
reduced efficiency, and that, under conditions of low expression, Env
molecules act cooperatively. These observations have important
consequences for our understanding of natural retroviral infection as
well as for the design of cell-targeted infection techniques involving
retroviral vectors.
 |
INTRODUCTION |
Retroviral env
gene-encoded glycoproteins (Env) form knobbed spikes on the surfaces of
virions and play a critical role in infection of target cells by
attaching viral particles to specific host cell receptors and mediating
the fusion of viral and host cell membranes (10, 22).
However, Env binding to the receptor is, most probably, not the primary
event of infection but rather is preceded by an Env-independent
adsorption step (39, 43). Envs are synthesized as
polyproteins targeted for translation to the endoplasmic reticulum via
cleaved amino-terminal signal peptides. They are subsequently subjected
to glycosylation, oligomerization, and further proteolytic processing
by cellular proteases to give two subunits remaining associated via
noncovalent (and sometimes covalent) bonds. These two subunits are SU,
a hydrophilic extracellular glycoprotein responsible for binding to
viral receptors, and TM, a transmembrane polypeptide tethering Env
complexes to viral particles and playing the major part in the fusion
of the viral envelope with the cellular membrane (10, 23,
28).
The structure and function of murine leukemia virus (MuLV) Env have
been studied in detail. On the basis of their host range, MuLVs have
been classified into six subgroups (ecotropic, amphotropic, polytropic,
xenotropic, MDEV, and 10A1) (10, 22). The envelope motifs
that bind to the various viral receptors and determine the infection
specificity have been mapped within the N-terminal one-third of SU
(gp70), which bears the most-variable regions of MuLV Envs (2-6,
13, 16, 21, 22, 34, 38, 41, 51). Thus, ecotropic MuLVs enter
cells after binding to a cationic amino acid transporter (CAT-1) and
amphotropic MuLVs enter cells after binding to a sodium-phosphate
symporter (PIT-2) (22). In addition to an amino-terminal
fusion peptide of TM [p15(E) in MuLVs] (16, 25, 56),
various fusion-influencing determinants have been identified. At the
level of SU, the latter include an N-terminal peptide (2)
and a central proline-rich region (29, 50) mediating
envelope conformational changes upon the binding of Env to its cognate
receptor, the consequences of which are fusion activation through the
unmasking of the TM N-terminal fusion peptide and the decreased
stability of SU-TM heterodimers (29). At the level of TM,
the last 16 amino acids (R peptide) exert a fusion-inhibitory effect in
virus-producing cells (24, 44, 45, 54, 56) relieved at the
time of budding or within virions through proteolytic processing of
p15(E) by the viral protease. Motifs important for correct SU-TM
interactions have also been identified. In addition to motifs
responsible for noncovalent interactions between MuLV subunits, SU and
TM are linked by a disulfide bond thought to be stable (40)
owing to a CWLC motif at the beginning of the C-terminal domain of SU
and a CX6CC sequence in TM (42). Moreover, one
signal for N-linked glycosylation, located at the beginning of the
C-terminal domain of SU, seems essential for both the folding of the
C-terminal domain of SU and the stability of the interactions between
SU and TM (33). In addition, a "leucine zipper-like"
motif or a motif contained within it, downstream of the fusion peptide
in the extracellular domain of p15(E), is essential for trimerization
of SU-TM heterodimers through homomeric interactions of TM subunits
(16, 32). However, there are also multiple other contacts in
both SU and TM domains responsible for oligomerization (49)
which allow functional interactions between SU-TM heterodimers within
envelope protein complexes (46, 53). Finally, it has
recently been found that, in addition to attaching MuLVs to their
receptors, SU also sensitizes cells to infection (30). This
last work also shows that, although they recognize different receptors
for binding to the cell surface, the different classes of MuLVs use a
common entry pathway, which is activated by a conserved feature of
their envelope glycoprotein (30).
So far, the quantitative aspects of cell infection by retroviruses have
been little documented. Analysis of the kinetics for the binding of
both purified Env and purified virions to cells (9, 14, 17, 26,
27, 51) has led to the idea that the binding of MuLV is
essentially due to multivalent noncooperative interactions whereby
viral particles, each bearing multiple copies of oligomeric Env, bind
to target cells, each bearing multiple copies of the receptor
(51). As another approach to address the issue of how many
Env-receptor interactions are necessary for infection, we have produced
MuLV particles expressing various amounts of ecotropic and amphotropic
Env. Unexpectedly, our data indicate that a small number of Env
molecules are sufficient for mediating infection, albeit at a low
efficiency. Surprisingly, they also show that the threshold of Env
abundance required for efficient infection is very low and that Env can
be incorporated in vast excess into viral particles with no further
improvement of viral titers. The implications of our observation are
discussed with respect to both wild-type infection and cell targeting
by recombinant retroviral vectors.
 |
MATERIALS AND METHODS |
Plasmids and expression vectors.
The pRL-TK
Renilla luciferase reporter plasmid was obtained from
Clontech. pUHC-13-3 expresses the firefly luciferase gene under the
control of the Tet operator, and pUHD-15-1 expresses the
tetracycline-regulatable tTA transactivator (19). Ecotropic and amphotropic Env sequences were amplified by PCR from plasmids FBEMOSALF and FB4070ASALF (11), respectively. They were then cloned into the EcoRI and XbaI sites and
SacII and XbaI sites located downstream of the
Tet operator sequences of the plasmid pUHD-10-3 (19) to give
the PM361 and PM377 tTA-responsive expression plasmids, respectively.
Cell lines.
TelCeb6 cells were derived from the TE671 human
rhabdomyosarcoma (11). They produce Env glycoprotein-lacking
retroviral particles carrying a nuclear localization
signal-
-galactosidase reporter gene. Tel A and 3A2B6 are stable
cell lines derived from TelCeb6 cells by transfection of amphotropic
and ecotropic Env expression vectors, respectively. Mouse NIH 3T3
fibroblasts, A431 human keratinocytes, H9 human T cells, and mouse
C2C12 myoblasts are available from the American Type Culture
Collection. TE671-derived cells and NIH 3T3 cells were cultured in
Dulbecco modified Eagle medium (DMEM) (Gibco/BRL), whereas A431 and H9
cells were grown in RPMI 1640 medium (Gibco/BRL) and C2C12 cells were
grown in a 1:1 mixture of HAM-F12 (Eurobio) and DMEM. All culture media were supplemented with a mixture of 10% heat-inactivated fetal calf
serum (Biomedia), 2 mM glutamine, 100 µg of streptomycin/ml, and 100 U of penicillin/ml.
Cell transfections.
Transient and stable transfections were
carried out using the calcium phosphate precipitation procedure
(48). The pRL-TK plasmid was used for normalization of
transient-transfection experiments. In this case, 2 × 105 cells per well of six-well culture plates (Nunc) were
transfected using 2 µg of the relevant plasmid plus 0.1 µg of
pRL-TK. To obtain stable virus-producing cell clones expressing
inducible ampho- and ecotropic Env, TelCeb6 cells were stably
transfected with pUHD-15-1 and individual clones were tested in
transient-transfection assays for their ability to express the firefly
luciferase gene from pUHC-13-3 in a doxycycline (DOX)-dependent manner.
The Tel179.9 clone used in this study was found to be the best
responder. It was then stably transfected with eco- and amphotropic Env
expression plasmids PM361 and PM377 to give CPM64 and CPM79 cells, respectively.
Luciferase and
-galactosidase assays and virus assay.
Renilla and firefly luciferase assays were carried out using
the dual-luciferase reporter assay system from Promega according to the
supplier's specifications. Assays of viruses were performed using cell
culture supernatants from virus-producing cells cultured at confluence
for 24 h. For assay of viruses on NIH 3T3, A431, and C2C12 cells,
2 × 104 target cells were plated in 12-well culture
plates (Nunc). Twenty-four hours later, the culture medium was removed
and replaced by 1 ml of fresh culture medium containing serially
diluted virus-containing culture supernatants and 8 µg of Polybrene
(Sigma)/ml. Infection was allowed to proceed overnight, the culture
medium was changed, and an X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) (Eurobio) assay of retrovirally infected cells was performed 48 h
later (36). For nonadherent H9 T cells virus assays were
performed using the fibronectin method as described in reference
12. For kinetic infection experiments, cells were
incubated in the presence of viruses for various periods of time and
rapidly washed three times with phosphate-buffered saline (PBS; 0.15 M
NaCl, 0.01 M NaPO4, pH 7) before the addition of fresh
culture medium. For the assay of viruses produced by cells transiently
transfected in the presence of various amounts of DOX, the culture
medium was replaced by fresh medium containing the same concentration of DOX 48 h posttransfection and viruses released in culture
supernatants were assayed and processed 16 h later. For the assay
of viruses produced by stable cell lines, the latter were grown to
confluence in the presence of various concentrations of DOX for at
least 24 h before replacement of the culture medium by fresh
medium containing the same concentration of DOX. Viruses were also
assayed and processed 18 h later.
FACS and immunoblotting assays of Env.
Env expression at the
cell surface was quantified by fluorescence-activated cell sorter
(FACS) analysis as described by Lavilette et al. (29) using
the 83A25 anti-Env monoclonal antibody (15). For
quantification of virion-associated Env by immunoblotting, 1.2 ml of
virus-containing culture supernatants was adjusted to 10 mM
CaCl2 and incubated at room temperature for 30 min.
Precipitated virions were spun down at 17,600 × g at
4°C for 1 min and resuspended directly in 10 µl of electrophoresis
loading buffer. For analysis of cell-associated Env, cells were washed
with PBS, scraped off culture dishes, centrifuged at 270 × g at 4°C for 5 min, resuspended in triplex lysis buffer (50 mM
Tris-HCl [pH 8], 150 mM NaCl, 0.2% NaN3, 0.1% sodium
dodecyl sulfate (SDS), 1% NP-40, 0.5% sodium deoxycholate, 2 mg of
leupeptin/ml, 1 mM phenylmethylsulfonyl fluoride), and incubated on ice
for 30 min. Cell debris and nuclei were removed by centrifugation
of samples at 17,600 × g at 4°C for 10 min. Protein
concentrations in supernatants were determined, and 75-µg samples
were processed for electrophoresis. Virus and cell protein samples were
fractionated through SDS-containing 10% polyacrylamide gels and
transferred on Protran nitrocellulose membranes (Schleicher and
Schuell), and immunodetections were carried out as described in
reference 36 using the anti-gp70 goat antibody from
Quality Biotech Inc. For viral particles, normalization of experiments
was obtained by reprobing membranes with the R187b monoclonal antibody
(8), which recognizes the MuLV p30Gag protein
under the conditions described in reference 37.
Densitometer analysis of luminograms exposed for appropriate periods of
time was performed using the National Institutes of Health IMAGE software.
 |
RESULTS |
Infection efficiency of virions expressing various amounts of
amphotropic Env in transient-transfection assays.
To address
whether the amount of Env influences the infection efficiency of MuLVs,
we first used a transient-transfection assay for production of
homogeneous populations of virions expressing different amounts of
Env. TelCeb6 cells produce Env-less noninfectious Moloney MuLV derived
retroviral particles expressing the bacterial
-galactosidase
reporter gene (11). They were engineered (clone Tel179.9) to
constitutively express the tTA transcriptional transactivator, the
activity of which is negatively regulated by DOX (19), and then were transiently transfected in the presence of various
concentrations of the drug with a plasmid (PM377) carrying a
tTA-responsive amphotropic Env gene. This approach was preferred over
transfection of various amounts of a constitutive expression plasmid
because it permits control of the ectopic gene in each transfected cell
whereas the second method has more effect on the number of transfected
cells than on the level of expression in each transfected cell.
Immunoblotting experiments using a specific anti-MuLV Env antiserum
were conducted in duplicate to assay for Env abundance in transfected
cells and in viral particles released in culture supernatants which
varied in both situations as a (nonlinear) function of DOX (Fig.
1Aa and 1Ab). FACS analysis of
transfected cells was also conducted to assay for cell
surface-associated Env at the individual-cell level (Fig. 1B). Under
the conditions tested (10 and 100 ng of DOX/ml), the vast majority of
cells (more than 80%) were found in sharp peaks of fluorescence
whereas the remaining cells, probably nontransfected or poorly
transfected cells, showed lower or no fluorescence. Overall, these data
point to a homogeneous expression of Env at the individual-cell level
in the vast majority of transfected cells under the experimental
conditions used. The mean fluorescence ratio of these peaks (2.3) was
comparable to the ratio of Env abundances (2.5) assayed by
immunoblotting, confirming the DOX dose-dependent accumulation of Env.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 1.
Infection of NIH 3T3 cells by virions expressing various
amounts of amphotropic Env in transient-transfection assays. Tel179.9
cells were transiently transfected with the PM377 amphotropic
Env-expressing vector in the presence of various concentrations of DOX.
(A) Env abundance assayed by immunoblotting. Equal amounts of cell
extracts (a) and viral particles (b) were processed for immunoblotting
analysis. Chemiluminescence detection was performed using a goat
anti-MuLV Env antiserum. Only luminograms corresponding to short
exposure times are presented in panels a and b. Longer exposures
allowed visualization of Env expression at the highest DOX doses and
thus quantification of signals (not shown). Both gp70 and its
noncleaved precursor form, gp85, were detected in cellular extracts,
and only gp70 was detected in experiments with viral particles. The
blot presented in panel b was stripped and reprobed with
anti-p30Gag capsid monoclonal antibodies to verify that
comparable amounts of viral proteins were analyzed in all tracks. The
slight variations in p30Gag protein abundance were taken
into account for normalization of gp70 abundance. C-, nontransfected
control cells. (B) FACS analysis of Env-expressing cells. Experiments
were conducted using the 83A25 anti-Env rat monoclonal antibody.
|
|
Infectious viruses released in culture supernatants were then assayed
in quadruplicate on NIH 3T3 murine embryo fibroblasts
(Fig.
2A), and titers were plotted against
relative Env abundances
deduced from densitometer scanning of
immunoblots made with viral
particles (Fig.
2B). The most striking
observation was the absence
of a linear relationship between Env
abundance and infection efficiency.
At the lowest DOX concentration (0 to 1 ng/ml), a 10-fold variation
in Env was not associated with any
significant variation in infectious
titers, indicating the existence of
a threshold above which better
incorporation of Env does not lead to
any improvement in infection
efficiency. At the highest doses of DOX
(1,000 and 100 ng/ml)
a 2-fold increase in Env abundance resulted in a
10-fold-higher
titer, raising the possibility of cooperation between
Env molecules
occurring at low density. At intermediate DOX
concentrations (1
to 100 ng/ml), variations in Env abundance were
associated with
variations in viral titers, supporting the idea that
multiple
Env-receptor interactions favor infection.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 2.
Infection of NIH 3T3 cells by virions expressing various
amounts of amphotropic Env in transient-transfection assays. (A) Cell
infection assays. Infectious viruses contained in culture supernatants
were assayed on NIH 3T3 cells in quadruplicate. (B) Relative Env
abundance versus relative infectious titers. Env abundance and
infectious titers assayed in the absence of DOX were taken as 100%
references. Relative Env abundances were deduced from densitometer
scanning analysis of luminograms exposed for various periods of time
for accurate comparison of the relative intensities of the various
signals. Error bars, standard deviations (A and B).
|
|
Infection efficiency of virions expressing various amounts of
ecotropic and amphotropic Env in stable-transfection assays.
We
then addressed whether the observed effect could be seen with another
MuLV Env. Stable Tel179.9 cell-derived clones expressing tTA-responsive
ecotropic (clone CPM64) and amphotropic (clone CPM79) Env genes were
derived for direct comparison of ecotropic and amphotropic Envs.
Virion-associated Envs and infectious particles contained in culture
supernatants of CPM64 and CPM79 cells cultured in the presence
of various concentrations of DOX were assayed in triplicate under
conditions similar to those used in transient-transfection experiments
(Fig. 3A and B and
4A and B, respectively). FACS analysis also showed homogenous expression of ecotropic and amphotropic Env at
the surfaces of virus-producing cells in the various conditions used
(data not shown).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 3.
Cell infection by virions expressing various amounts of
ecotropic Env in stable-transfection assays. CPM64 cells were cultured
in the presence of various concentrations of DOX. (A) Immunoblotting
assay of Env (a) and p30Gag (b) associated with viral
particles contained in culture supernatant. A luminogram corresponding
to a short exposure time is presented in panel a. p30Gag
abundance was used to normalize Env abundance. C-, Tel179.9 control
cells. (B) Assay of infectious particles on NIH 3T3 cells and on C2C12.
(C) Relative Env abundance versus relative infectious titers assayed on
NIH 3T3 cells. An immunoblotting assay of Env was performed in
duplicate, and relative abundances were deduced from densitometer
scanning analysis of luminograms exposed for various periods of time
for accurate comparison of signals. Infectious titers were determined
in triplicate, and error bars indicate standard deviations (B and C).
|
|

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 4.
Cell infection by virions expressing various amounts of
amphotropic Env in stable-transfection assays. CPM79 cells were
cultured in the presence of various concentrations of DOX. (A)
Immunoblotting assay of Env (a) and p30Gag (b) associated
with viral particles contained in culture supernatant. A luminogram
corresponding to a short exposure time is presented in panel a.
p30Gag abundance was used to normalize Env abundance. C-,
Tel179.9 control cells. (B) Assay of infectious particles on NIH 3T3,
A431, and H9 cells. (C) Relative Env abundance versus relative
infectious titers assayed on NIH 3T3 cells. An immunoblotting assay of
Env was performed in duplicate, and relative abundances were deduced
from densitometer scanning analysis of luminograms exposed for various
periods of time. Infectious titers were determined in triplicate, and
error bars indicate standard deviations (B and C).
|
|
It is worthy of note that the drop in Env abundance observed between 0 and 0.1 ng of DOX/ml was more dramatic than that seen
in the
transient-transfection experiments. The reason for this
effect was not
investigated but might simply reflect the differential
responsiveness
to tTa of chromatin-associated and non-chromatin-associated
Tet-responsive genes. This, however, did not change, in their
essence,
the essential outcomes of the experiments since (i) at
the lowest DOX
concentrations (0 and 0.1 ng/ml), 50- and 80-fold
variations in
ecotropic and amphotropic Env, respectively, did
not result in any
change in infectious virus titers, (ii) at intermediate
concentrations,
a reduction in Env abundance resulted in less-efficient
infection, and
(iii) at the highest concentrations used, a synergistic
effect between
Env molecules was also observed. Thus, for ecotropic
Env, the 2- and
3-fold increases in abundances between 10 and
1 ng/ml and between 1 and
0.1 ng/ml resulted in 30- and 10-fold-higher
titers, respectively (Fig.
3C). Similarly, for amphotropic Env,
the 2-fold increments in
amphotropic Env abundance between 100
and 10 ng/ml and between 10 and 1 ng/ml resulted in 10- and 40-fold
elevations in infectious titers,
respectively (Fig.
4C). Unfortunately,
raising the DOX concentration
above 100 and 1,000 ng/ml when using
CPM64 and CPM79 cells (not shown),
respectively, did not allow
a further diminishing of Env expression
because of the leakiness
of the tetracycline expression system, and
total infection inhibition
could thus not be achieved using these cell
lines. Low levels
of infection at high DOX concentrations were,
however, clearly
Env dependent because no infectious viruses were
detected in parallel
experiments using Tel179.9 cells as a source of
viral
particles.
Infection efficiency of virions expressing various amounts of
ecotropic and amphotropic Env for various cell types.
Next, we
determined whether the observed effect was cell type independent. In
one series of experiments, culture supernatant from CPM64 cells grown
in the presence of various concentrations of DOX were used to infect
murine myogenic C2C12 cells (Fig. 3B), and, in a second series, culture
supernatants from CPM79 cells were used to infect human keratinocytic
A431 cells and H9 T lymphocytes (Fig. 4B). The final outcomes of these
experiments were very similar to those of experiments involving NIH 3T3
cells as target cells. The only noticeable difference was the lower
sensitivity of A431 and H9 cells to infection.
Infection kinetics using retroviruses expressing different amounts
of ecotropic and amphotropic Env.
We next addressed whether the
amount of Env could influence the kinetics of cell infection by MuLVs
by conducting duplicate infection experiments in which NIH 3T3 cells
were exposed for various periods of time to culture supernatants of
CPM64 and CPM79 cells cultured in the absence or the presence of 0.1 ng
of DOX/ml. In parallel, variations in virion-associated Env abundance
were controlled by immunoblotting. In an initial phase (0 to 20 min), a
rapid increase in the number of infected cells was observed under both
conditions, indicating a rapid attachment of virions to cells (also see
references 43 and 51) (Fig.
5). In the absence of DOX, a plateau was
then rapidly reached (between 30 and 60 min), whereas in the presence
of 0.1 ng of DOX/ml, where 50- and 80-fold less ecotropic and
amphotropic Env was associated with viruses, respectively, the same
plateau as that described above was eventually reached (which is
consistent with the experiments presented in Fig. 1 to 3) but it was
reached much more slowly (by 120 min). Since adsorption of Env-bearing
MuLVs and that of Env-lacking MuLVs to target cells occur equally
efficiently and equally rapidly (43), these data suggest
that the reduction in the amount of virion-associated Env primarily
affects the rate of postadsorption steps of the infection process and
permits elimination of adsorbed virions from the cell surface by
washing in experiments for infection kinetics (see Discussion). The
initial rapid increase in infected cells in the experiments carried out
in the presence of 0.1 ng of DOX/ml deserved a comment since it raises
the possibility of the presence of a very minor fraction of viruses
that incorporated larger amounts of Env and that could bind
irreversibly to cells at a high rate. Although this would influence the
shape of the curve, it does not change our overall conclusion that
diminishing Env density entails a slowing down of infectious attachment
to cells.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 5.
Infection kinetics of NIH 3T3 cells by virions
expressing different amounts of Env. CPM64 and CPM79 cells were
cultured in the presence of various concentrations of DOX. For
infection experiments, which were carried out in triplicate, culture
supernatants were added to NIH 3T3 cells for various periods of time
and then washed out using PBS. Infected cells were scored 3 days
later.
|
|
 |
DISCUSSION |
It is commonly assumed that many noncooperative Env-receptor
interactions are necessary for efficient retrovirus entry into cells.
Unexpectedly, for MuLVs a very small amount of Env per viral particle
was shown here to be sufficient to permit cell infection since a 100- to 200-fold reduction in Env level dramatically reduces but does not
totally abolish infection by MuLV-derived vectors. In line with this
conclusion, Zavorotinskaya and Albritton (52) have recently
reported that virions incorporating unprocessed precursor molecules as
a predominant species because of a deficiency in SU-TM proteolytic
processing and processed Env as a very minor species retain part of
their infectious potential, indicating that the presence of only a few
mature TM proteins (i.e., molecules capable of exposing a free
N-terminal fusion peptide) is sufficient to permit fusion of the viral
envelope and cell membrane. Because functional interactions between
SU-TM heterodimers can occur within Env trimers (46, 53),
these authors, however, could not exclude possible cooperation between
processed and unprocessed Envs. Our data now support the notion that
both the recognition of the receptor and the formation of the fusion
pore can be achieved by a limited number of mature Env molecules.
Unfortunately, this number could not be quantified exactly in our
experiments because the leakiness of the expression system used did not
allow the identification of conditions of total cell infection
inhibition (not shown). It can, however, be reasonably estimated not to
exceed 10 molecules or a few more if it is taken into consideration
that natural MuLVs express several hundred (200 to 400) Env molecules
(51) by analogy with human immunodeficiency virus type 1 (HIV-1) and -2 retroviruses (18) and that MuLV-based vectors
incorporate only slightly larger Env amounts under optimized
env gene expression in packaging cell lines. Also supporting
the idea that a limited amount of envelope glycoprotein is sufficient
for virus entry into cells is the recent observation that as few as one
hemagglutinin trimer may trigger fusion of influenza virus with
infected cells (20).
Our data show that infection efficiency is dependent on Env density up
to a threshold amount above which an apparently large excess of Env can
be incorporated without improving infection titers whatever the target
cell used. Moreover, they also raise the possibility of cooperation
between Envs when small amounts of Env are incorporated in viral
particles. Definite proof of cooperativity will, however, have to await
techniques comparable to FACS analysis for cells, permitting the assay
of small amounts of incorporated Env at the level of individual viral
particles to exclude formally the possibility that a fraction of viral
particles expressing significantly larger amounts of Env could bias
infection assays carried out at the highest concentration of DOX. The
experiments for infection kinetics conducted in the presence of 0.1 ng
of DOX/ml (Fig. 5), however, suggest that the fraction of viral
particles expressing significantly higher amounts of Env, if it exists, is most likely very minor. The mechanisms underlying cooperativity are
still elusive and are possibly severalfold. A first possibility could
be the existence of functional interactions between Env trimers for
either recruiting several receptors or for forming more-efficient
fusion pores after the binding of viruses to one receptor or to a very
limited number of receptors. Another possible mechanism would rely on
the possibility for Env monomers (each monomer comprising SU and TM) to
dissociate and reassociate at the surfaces of viral particles;
increasing Env density would thus favor reassociation of Env monomers
and, consequently, functional cooperation within trimers. Studying the
multimerization state of Env molecules incorporated at low density in
virions should help to address these two non-mutually exclusive
possibilities. One could, for example, envisage that, at low density,
increasing the amount of Env initially favors functional interactions
within Env trimers and then functional interactions between trimers. A
possible mechanism takes into account the recent finding that SU not
only permits virion attachment to the viral receptor but also
sensitizes cells for infection (30); increasing the amount of Env would thus result not only in a binding to more receptors but
also in a better sensitization of target cells to infection.
The observation that virions can incorporate an apparently vast excess
of Env is intriguing. Whether incorporation of large amounts of Env is
necessary to compensate for the propensity of Env to shed
(1) deserves further investigation. Without excluding this
possibility, our experiments are consistent with the idea that
augmenting Env density accelerates the infection process. Since
retroviruses rapidly adsorb onto cells in an Env-independent manner
before, most probably, browsing the cell surface until they encounter
the viral receptors (43), it is possible that delayed
infectious attachment of virions at reduced Env density simply reflects
a reduction in the frequency of virus binding to the cognate receptor
during the cell surface scanning phase of infection. Alternatively,
high Env density might result in a faster sensitization of cells to
infection and, as a consequence, in a faster entry of virions into
cells. This observation also raises two interesting biological issues.
First, our experiments have been conducted exclusively in vitro. The
possibility that large amounts of Env are required for efficient viral
replication in vivo cannot yet be excluded. Second, we have used eco-
and amphotropic MuLVs, which, interestingly, use different receptors for entry into cells although they most probably use a common entry
pathway activated by conserved features of their envelope glycoprotein
(30). It would now be interesting to establish whether our
observations also apply to other MuLV subtypes as well as to other
retroviruses or, more generally, to enveloped viruses. From experiments
based on the blocking of HIV infection by soluble CD4 molecules, Layne
et al. (31) have already concluded that the HIV envelope is
covered by a redundant number of gp120 molecules and that efficient
CD4-mediated infection requires multiple gp120 molecules. Experiments
are under way to address this point on a novel quantitative basis.
Recombinant MuLVs are widely used as gene transfer vectors both in the
laboratory and in clinical protocols although this technology still
suffers from a number of limitations. More specifically, the
development of efficient cell-targeting techniques based on the genetic
engineering of Env has met with difficulties since, when it is
successful, redefined infection usually occurs at low yields (28,
35, 47). Poor targeting efficiency is attributable, at least in
part, to poor fusion activity of reshaped Env (7, 55), but
it is commonly thought that reduced incorporation of modified Env into
virions is also detrimental to infection. Our work suggests that this
might not necessarily be the case, especially when long incubations
(hours) with target cells are possible because Env density, at least
above a certain threshold, primarily acts on the kinetics of infection
and has little, if any, effect on the final infection yield. However,
when infection cannot be carried out for long periods of time (1 h or
less), our results also suggest that ensuring high incorporation of
engineered Env into viral Env is necessary for achieving efficient
targeted infection.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the Centre National de la
Recherche Scientifique, the Agence Nationale contre le SIDA, the
Association de Recherche contre le Cancer, the Ligue contre le Cancer,
and the Association Française contre les Myopathies.
We are grateful to J.-L. Battini, F.-L. Cosset, D. Kabat, A. Oates, and
M. Sitbon for fruitful discussions and critical reading of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut de
Génétique Moléculaire, UMR 5535/IFR24, CNRS, BP 5051, 1919, Route de Mende, 34293 Montpellier Cedex 05, France. Phone: (33) 4 67 61 36 68. Fax: (33) 4 67 04 02 31. E-mail:
piechaczyk{at}igm.cnrs-mop.fr.
 |
REFERENCES |
| 1.
|
Andersen, K. B.
1994.
A domain of murine retrovirus surface protein gp70 mediates cell fusion, as shown in a novel SC-1 cell fusion system.
J. Virol.
68:3175-3182[Abstract/Free Full Text].
|
| 2.
|
Bae, Y.,
S. M. Kingsman, and A. J. Kingsman.
1997.
Functional dissection of the Moloney murine leukemia virus envelope protein gp70.
J. Virol.
71:2092-2099[Abstract].
|
| 3.
|
Battini, J. L.,
O. Danos, and J. M. Heard.
1998.
Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor.
J. Virol.
72:428-435[Abstract/Free Full Text].
|
| 4.
|
Battini, J. L.,
O. Danos, and J. M. Heard.
1995.
Receptor-binding domain of murine leukemia virus envelope glycoproteins.
J. Virol.
69:713-719[Abstract].
|
| 5.
|
Battini, J. L.,
J. M. Heard, and O. Danos.
1992.
Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses.
J. Virol.
66:1468-1475[Abstract/Free Full Text].
|
| 6.
|
Battini, J. L.,
P. Rodrigues,
R. Muller,
O. Danos, and J. M. Heard.
1996.
Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein.
J. Virol.
70:4387-4393[Abstract].
|
| 7.
|
Benedict, C. A.,
R. Y. Tun,
D. B. Rubinstein,
T. Guillaume,
P. M. Cannon, and W. F. Anderson.
1999.
Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion.
Hum. Gene Ther.
10:545-557[CrossRef][Medline].
|
| 8.
|
Chesebro, B.,
W. Britt,
L. Evans,
K. Wehrly,
J. Nishio, and M. Cloyd.
1983.
Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus.
Virology
127:134-148[CrossRef][Medline].
|
| 9.
|
Choppin, J.,
L. Schaffar-Deshayes,
P. Debre, and J. P. Levy.
1981.
Lymphoid cell surface receptor for Moloney leukemia virus envelope glycoprotein gp71. I. Binding characteristics.
J. Immunol.
126:2347-2351[Abstract].
|
| 10.
|
Coffin, J. M.,
S. H. Hughes, and H. E. Varmus (ed.).
1997.
Retroviruses.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 11.
|
Cosset, F. L.,
Y. Takeuchi,
J. L. Battini,
R. A. Weiss, and M. K. Collins.
1995.
High-titer packaging cells producing recombinant retroviruses resistant to human serum.
J. Virol.
69:7430-7436[Abstract].
|
| 12.
|
Dardalhon, V.,
N. Noraz,
K. Pollok,
C. Rebouissou,
M. Boyer,
A. Q. Bakker,
H. Spits, and N. Taylor.
1999.
Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes.
Hum. Gene Ther.
10:5-14[CrossRef][Medline].
|
| 13.
|
Davey, R. A.,
Y. Zuo, and J. M. Cunningham.
1999.
Identification of a receptor-binding pocket on the envelope protein of Friend murine leukemia virus.
J. Virol.
73:3758-3763[Abstract/Free Full Text].
|
| 14.
|
Eiden, M. V.,
K. Farrell,
J. Warsowe,
L. C. Mahan, and C. A. Wilson.
1993.
Characterization of a naturally occurring ecotropic receptor that does not facilitate entry of all ecotropic murine retroviruses.
J. Virol.
67:4056-4061[Abstract/Free Full Text].
|
| 15.
|
Evans, L. H.,
R. P. Morrison,
F. G. Malik,
J. Portis, and W. J. Britt.
1990.
A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses.
J. Virol.
64:6176-6183[Abstract/Free Full Text].
|
| 16.
|
Fass, D.,
S. C. Harrison, and P. S. Kim.
1996.
Retrovirus envelope domain at 1.7 angstrom resolution.
Nat. Struct. Biol.
3:465-469[CrossRef][Medline].
|
| 17.
|
Ganguly, K.,
V. S. Kalyanaraman, and M. G. Sarngadharan.
1983.
Analysis of the interaction between Rauscher murine leukemia virus and murine cell membrane receptor by in vitro binding assay.
Cancer Lett.
18:79-86[CrossRef][Medline].
|
| 18.
|
Gelderblom, H. R.
1991.
Assembly and morphology of HIV: potential effect of structure on viral function.
AIDS
5:617-638[Medline].
|
| 19.
|
Gossen, M.,
S. Freundlieb,
G. Bender,
G. Muller,
W. Hillen, and H. Bujard.
1995.
Transcriptional activation by tetracyclines in mammalian cells.
Science
268:1766-1769[Abstract/Free Full Text].
|
| 20.
|
Gunther-Ausborn, S.,
P. Schoen,
I. Bartoldus,
J. Wilschut, and T. Stegmann.
2000.
Role of hemagglutinin surface density in the initial stages of influenza virus fusion: lack of evidence for cooperativity.
J. Virol.
74:2714-2720[Abstract/Free Full Text].
|
| 21.
|
Han, J. Y.,
P. M. Cannon,
K. M. Lai,
Y. Zhao,
M. V. Eiden, and W. F. Anderson.
1997.
Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus.
J. Virol.
71:8103-8108[Abstract].
|
| 22.
|
Han, J. Y.,
Y. Zhao,
W. F. Anderson, and P. M. Cannon.
1998.
Role of variable regions A and B in receptor binding domain of amphotropic murine leukemia virus envelope protein.
J. Virol.
72:9101-9108[Abstract/Free Full Text].
|
| 23.
|
Hunter, E.
1997.
Viral entry and receptors, p. 71-120.
In
J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 24.
|
Januszeski, M. M.,
P. M. Cannon,
D. Chen,
Y. Rozenberg, and W. F. Anderson.
1997.
Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein.
J. Virol.
71:3613-3619[Abstract].
|
| 25.
|
Jones, J. S., and R. Risser.
1993.
Cell fusion induced by the murine leukemia virus envelope glycoprotein.
J. Virol.
67:67-74[Abstract/Free Full Text].
|
| 26.
|
Kadan, M. J.,
S. Sturm,
W. F. Anderson, and M. A. Eglitis.
1992.
Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis.
J. Virol.
66:2281-2287[Abstract/Free Full Text].
|
| 27.
|
Kalyanaraman, V. S.,
M. G. Sarngadharan, and R. C. Gallo.
1978.
Characterization of Rauscher murine leukemia virus envelope glycoprotein receptor in membranes from murine fibroblasts.
J. Virol.
28:686-696[Abstract/Free Full Text].
|
| 28.
|
Karavanas, G.,
M. Marin,
B. Salmons,
W. H. Gunzburg, and M. Piechaczyk.
1998.
Cell targeting by murine retroviral vectors.
Crit. Rev. Oncol. Hematol.
28:7-30[Medline].
|
| 29.
|
Lavillette, D.,
M. Maurice,
C. Roche,
S. J. Russell,
M. Sitbon, and F. L. Cosset.
1998.
A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes.
J. Virol.
72:9955-9965[Abstract/Free Full Text].
|
| 30.
|
Lavillette, D.,
A. Ruggieri,
S. J. Russell, and F. L. Cosset.
2000.
Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments.
J. Virol.
74:295-304[Abstract/Free Full Text].
|
| 31.
|
Layne, S. P.,
M. J. Merges,
M. Dembo,
J. L. Spouge, and P. L. Nara.
1990.
HIV requires multiple gp120 molecules for CD4-mediated infection.
Nature
346:277-279[CrossRef][Medline].
|
| 32.
|
Li, X.,
B. McDermott,
B. Yuan, and S. P. Goff.
1996.
Homomeric interactions between transmembrane proteins of Moloney murine leukemia virus.
J. Virol.
70:1266-1270[Abstract].
|
| 33.
|
Li, Z.,
A. Pinter, and S. C. Kayman.
1997.
The critical N-linked glycan of murine leukemia virus envelope protein promotes both folding of the C-terminal domains of the precursor polyprotein and stability of the postcleavage envelope complex.
J. Virol.
71:7012-7019[Abstract].
|
| 34.
|
MacKrell, A. J.,
N. W. Soong,
C. M. Curtis, and W. F. Anderson.
1996.
Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding.
J. Virol.
70:1768-1774[Abstract].
|
| 35.
|
Marin, M.,
D. Noël, and M. Piechaczyk.
1997.
Towards efficient cell targeting by recombinant retroviruses.
Mol. Med. Today
3:396-403[CrossRef][Medline].
|
| 36.
|
Marin, M.,
D. Noel,
S. Valsesia-Wittman,
F. Brockly,
M. Etienne-Julan,
S. Russell,
F. L. Cosset, and M. Piechaczyk.
1996.
Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins.
J. Virol.
70:2957-2962[Abstract].
|
| 37.
|
Marin, M.,
M. Pelegrin,
E. Bachrach,
D. Noël,
F. Brockly, and M. Piechaczyk.
2000.
Antiviral activity of an intracellularly expressed single-chain antibody fragment directed against the murine leukemia virus capsid protein.
Hum. Gene Ther.
11:389-401[CrossRef][Medline].
|
| 38.
|
Morgan, R. A.,
O. Nussbaum,
D. D. Muenchau,
L. Shu,
L. Couture, and W. F. Anderson.
1993.
Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins.
J. Virol.
67:4712-4721[Abstract/Free Full Text].
|
| 39.
|
Notter, M. F.,
J. F. Leary, and P. C. Balduzzi.
1982.
Adsorption of Rous sarcoma virus to genetically susceptible and resistant chicken cells studied by laser flow cytometry.
J. Virol.
41:958-964[Abstract/Free Full Text].
|
| 40.
|
Opstelten, D. J.,
M. Wallin, and H. Garoff.
1998.
Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex.
J Virol.
72:6537-6545[Abstract/Free Full Text]. (Erratum, 72:8460.)
|
| 41.
|
Ott, D., and A. Rein.
1992.
Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU.
J. Virol.
66:4632-4638[Abstract/Free Full Text].
|
| 42.
|
Pinter, A.,
R. Kopelman,
Z. Li,
S. C. Kayman, and D. A. Sanders.
1997.
Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes.
J. Virol.
71:8073-8077[Abstract].
|
| 43.
|
Pizzato, M.,
S. A. Marlow,
E. D. Blair, and Y. Takeuchi.
1999.
Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction.
J. Virol.
73:8599-8611[Abstract/Free Full Text].
|
| 44.
|
Ragheb, J. A., and W. F. Anderson.
1994.
pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry.
J. Virol.
68:3220-3231[Abstract/Free Full Text].
|
| 45.
|
Rein, A.,
J. Mirro,
J. G. Haynes,
S. M. Ernst, and K. Nagashima.
1994.
Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
J. Virol.
68:1773-1781[Abstract/Free Full Text].
|
| 46.
|
Rein, A.,
C. Yang,
J. A. Haynes,
J. Mirro, and R. W. Compans.
1998.
Evidence for cooperation between murine leukemia virus Env molecules in mixed oligomers.
J. Virol.
72:3432-3435[Abstract/Free Full Text].
|
| 47.
|
Russell, S. J., and F.-L. Cosset.
1999.
Modifying the host-range properties of retroviral vectors.
J. Gene Med.
1:300-311[CrossRef][Medline].
|
| 48.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 49.
|
Tucker, S. P.,
R. V. Srinivas, and R. W. Compans.
1991.
Molecular domains involved in oligomerization of the Friend murine leukemia virus envelope glycoprotein.
Virology
185:710-720[CrossRef][Medline].
|
| 50.
|
Wu, B. W.,
P. M. Cannon,
E. M. Gordon,
F. L. Hall, and W. F. Anderson.
1998.
Characterization of the proline-rich region of murine leukemia virus envelope protein.
J. Virol.
72:5383-5391[Abstract/Free Full Text].
|
| 51.
|
Yu, H.,
N. Soong, and W. F. Anderson.
1995.
Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells.
J. Virol.
69:6557-6562[Abstract].
|
| 52.
|
Zavorotinskaya, T., and L. M. Albritton.
1999.
Failure to cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction.
J. Virol.
73:5621-5629[Abstract/Free Full Text].
|
| 53.
|
Zhao, Y.,
S. Lee, and W. F. Anderson.
1997.
Functional interactions between monomers of the retroviral envelope protein complex.
J. Virol.
71:6967-6972[Abstract].
|
| 54.
|
Zhao, Y.,
L. Zhu,
C. A. Benedict,
D. Chen,
W. F. Anderson, and P. M. Cannon.
1998.
Functional domains in the retroviral transmembrane protein.
J. Virol.
72:5392-5398[Abstract/Free Full Text].
|
| 55.
|
Zhao, Y.,
L. Zhu,
S. Lee,
L. Li,
E. Chang,
N. W. Soong,
D. Douer, and W. F. Anderson.
1999.
Identification of the block in targeted retroviral-mediated gene transfer.
Proc. Natl. Acad. Sci. USA
96:4005-4010[Abstract/Free Full Text].
|
| 56.
|
Zhu, N. L.,
P. M. Cannon,
D. Chen, and W. F. Anderson.
1998.
Mutational analysis of the fusion peptide of Moloney murine leukemia virus transmembrane protein p15E.
J. Virol.
72:1632-1639[Abstract/Free Full Text].
|
Journal of Virology, September 2000, p. 8480-8486, Vol. 74, No. 18
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sandrin, V., Cosset, F.-L.
(2006). Intracellular Versus Cell Surface Assembly of Retroviral Pseudotypes Is Determined by the Cellular Localization of the Viral Glycoprotein, Its Capacity to Interact with Gag, and the Expression of the Nef Protein. J. Biol. Chem.
281: 528-542
[Abstract]
[Full Text]
-
O'Reilly, L., Roth, M. J.
(2003). G541R within the 4070A TM Protein Regulates Fusion in Murine Leukemia Viruses. J. Virol.
77: 12011-12021
[Abstract]
[Full Text]
-
Dreja, H., Gros, L., Villard, S., Bachrach, E., Oates, A., Granier, C., Chardes, T., Mani, J.-C., Piechaczyk, M., Pelegrin, M.
(2003). Monoclonal Antibody 667 Recognizes the Variable Region A Motif of the Ecotropic Retrovirus CasBrE Envelope Glycoprotein and Inhibits Env Binding to the Viral Receptor. J. Virol.
77: 10984-10993
[Abstract]
[Full Text]
-
Lu, C.-W., O'Reilly, L., Roth, M. J.
(2002). G100R Mutation within 4070A Murine Leukemia Virus Env Increases Virus Receptor Binding, Kinetics of Entry, and Viral Transduction Efficiency. J. Virol.
77: 739-743
[Abstract]
[Full Text]
-
Barnett, A. L., Davey, R. A., Cunningham, J. M.
(2001). Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection. Proc. Natl. Acad. Sci. USA
98: 4113-4118
[Abstract]
[Full Text]